Immediate Impact
57 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Works of F. Tuci being referenced
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit
2014
Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna Experience
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| F. Tuci | 347 | 247 | 212 | 24 | 498 | |
| Yoram Menachem | 119 | 211 | 142 | 22 | 485 | |
| Zhenwen Liu | 206 | 234 | 124 | 28 | 547 | |
| Muhammed Yüksel | 278 | 180 | 201 | 20 | 526 | |
| Satheesh Iype | 90 | 202 | 133 | 23 | 455 | |
| Dan‐Avi Landau | 270 | 97 | 152 | 22 | 548 | |
| Nicola Zucchini | 132 | 126 | 180 | 28 | 529 | |
| Monika Hurtova | 345 | 194 | 249 | 17 | 476 | |
| B Uzunalimoğlu | 197 | 188 | 155 | 28 | 418 | |
| Teresa Urraro | 434 | 78 | 266 | 15 | 508 | |
| Grace Hartman | 135 | 244 | 108 | 22 | 423 |
All Works
Loading papers...